NG
NervGen Pharma Corp. Common stock (NGEN)
NASDAQ·Healthcare·Biotechnology
$1.60
-0.62%
Mkt Cap $132.33M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+650.0%
Consensus $12.00 vs current $1.60